Neoadjuvant Therapy of Pancreatic Ductal Adenocarcinoma With Vascular Involvement Shows Promise

被引:0
作者
Massoumi, Roxanne L. [1 ]
Hines, O. Joe [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, 10833 Le Conte Ave,72-180 CHS, Los Angeles, CA 90095 USA
关键词
D O I
10.1001/jamasurg.2019.2278
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:942 / 942
页数:1
相关论文
共 3 条
[1]  
American Cancer Society, 2019, Cancer Treatment Survivorship Facts Figures 2019-2021, DOI DOI 10.1080/15398285.2012.701177
[2]   Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma [J].
Maggino, Laura ;
Malleo, Giuseppe ;
Marchegiani, Giovanni ;
Viviani, Elena ;
Nessi, Chiara ;
Ciprani, Debora ;
Esposito, Alessandro ;
Landoni, Luca ;
Casetti, Luca ;
Tuveri, Massimiliano ;
Paiella, Salvatore ;
Casciani, Fabio ;
Sereni, Elisabetta ;
Binco, Alessandra ;
Bonamini, Deborah ;
Secchettin, Erica ;
Auriemma, Alessandra ;
Merz, Valeria ;
Simionato, Francesca ;
Zecchetto, Camilla ;
D'Onofrio, Mirko ;
Melisi, Davide ;
Bassi, Claudio ;
Salvia, Roberto .
JAMA SURGERY, 2019, 154 (10) :932-942
[3]   CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer [J].
Williams, Jennifer L. ;
Kadera, Brian E. ;
Nguyen, Andrew H. ;
Muthusamy, V. Raman ;
Wainberg, Zev A. ;
Hines, O. Joe ;
Reber, Howard A. ;
Donahue, Timothy R. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (07) :1331-1342